Japan Tissue Engineering Co Ltd
TSE:7774
Intrinsic Value
Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. [ Read More ]
The intrinsic value of one Japan Tissue Engineering Co Ltd stock under the Base Case scenario is 281.67 JPY. Compared to the current market price of 605 JPY, Japan Tissue Engineering Co Ltd is Overvalued by 53%.
Valuation Backtest
Japan Tissue Engineering Co Ltd
Run backtest to discover the historical profit from buying and selling Japan Tissue Engineering Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Japan Tissue Engineering Co Ltd
| Current Assets | 5.2B |
| Cash & Short-Term Investments | 4.1B |
| Receivables | 475.6m |
| Other Current Assets | 669.4m |
| Non-Current Assets | 1.7B |
| PP&E | 1.5B |
| Intangibles | 98.5m |
| Other Non-Current Assets | 40.9m |
| Current Liabilities | 942.4m |
| Accounts Payable | 80.6m |
| Accrued Liabilities | 63.3m |
| Other Current Liabilities | 798.5m |
| Non-Current Liabilities | 34.9m |
| Other Non-Current Liabilities | 34.9m |
Earnings Waterfall
Japan Tissue Engineering Co Ltd
|
Revenue
|
2.4B
JPY
|
|
Cost of Revenue
|
-854.2m
JPY
|
|
Gross Profit
|
1.5B
JPY
|
|
Operating Expenses
|
-1.7B
JPY
|
|
Operating Income
|
-155.3m
JPY
|
|
Other Expenses
|
-1.9m
JPY
|
|
Net Income
|
-157.2m
JPY
|
Free Cash Flow Analysis
Japan Tissue Engineering Co Ltd
Profitability Score
Profitability Due Diligence
Japan Tissue Engineering Co Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Japan Tissue Engineering Co Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Japan Tissue Engineering Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Japan Tissue Engineering Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Japan Tissue Engineering Co Ltd
According to Wall Street analysts, the average 1-year price target for Japan Tissue Engineering Co Ltd is 1 224 JPY with a low forecast of 1 212 JPY and a high forecast of 1 260 JPY.
Shareholder Return
Price
Japan Tissue Engineering Co Ltd
| Average Annual Return | -16.27% |
| Standard Deviation of Annual Returns | 12.28% |
| Max Drawdown | -56% |
| Market Capitalization | 24.6B JPY |
| Shares Outstanding | 40 609 954 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.
Contact
IPO
Employees
Officers
The intrinsic value of one Japan Tissue Engineering Co Ltd stock under the Base Case scenario is 281.67 JPY.
Compared to the current market price of 605 JPY, Japan Tissue Engineering Co Ltd is Overvalued by 53%.
You don't have any saved screeners yet
